We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.59B
AUM Growth
+$160M
Cap. Flow
-$54.6M
Cap. Flow %
-3.43%
Top 10 Hldgs %
16.55%
Holding
226
New
31
Increased
63
Reduced
63
Closed
27

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$19M
2
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
+$16.3M
3
AMRS
Amyris Inc.
AMRS
+$14.3M
4
ESTA icon
Establishment Labs
ESTA
+$12.8M
5
SQSP
Squarespace, Inc.
SQSP
+$9.51M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$20M
2
NVCR icon
NovoCure
NVCR
+$14.8M
3
SEER icon
Seer Inc
SEER
+$14.5M
4
JBLU icon
JetBlue
JBLU
+$14.2M
5
AXSM icon
Axsome Therapeutics
AXSM
+$7.85M

Sector Composition

Rank Sector Weight
1 Healthcare 44.51%
2 Technology 13.21%
3 Financials 6.93%
4 Consumer Discretionary 6.6%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LIND icon
126
Lindblad Expeditions
LIND
$2.22B
$2.17M 0.14%
135,633
+22,033
+19% +$373K
SNPS icon
127
Synopsys
SNPS
$79.7B
$2.12M 0.13%
7,682
-1,338
-15% -$340K
OKUR
128
OnKure Therapeutics
OKUR
$168M
$2.11M 0.13%
+22,619
New +$2.52M
GNRC icon
129
Generac Holdings
GNRC
$12.5B
$2.07M 0.13%
4,982
-74
-1% -$24.8K
MCRI icon
130
Monarch Casino & Resort
MCRI
$2.23B
$1.89M 0.12%
28,493
+138
+0.5% +$9.53K
CMIIU
131
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
$1.83M 0.11%
135,744
+12,439
+10% +$166K
KLAC icon
132
KLA
KLAC
$259B
$1.82M 0.11%
56,020
-15,660
-22% -$502K
SNTI icon
133
Senti Biosciences Holdings
SNTI
$11M
$1.74M 0.11%
+17,500
New +$1.75M
BKR icon
134
Baker Hughes
BKR
$61.1B
$1.72M 0.11%
+75,000
New +$1.73M
LUXE
135
LuxExperience B.V.
LUXE
$1.11B
$1.35M 0.09%
+44,536
New +$1.32M
CDNS icon
136
Cadence Design Systems
CDNS
$93.4B
$1.26M 0.08%
9,219
-2,254
-20% -$299K
DAR icon
137
Darling Ingredients
DAR
$9.44B
$1.23M 0.08%
+18,189
New +$1.28M
BURL icon
138
Burlington
BURL
$23.2B
$1.19M 0.07%
3,709
+1,784
+93% +$568K
AMZN icon
139
Amazon
AMZN
$2.96T
$1.09M 0.07%
6,320
-3,540
-36% -$588K
FHN icon
140
First Horizon
FHN
$12.1B
$1.06M 0.07%
61,203
+24,810
+68% +$450K
ADI icon
141
Analog Devices
ADI
$190B
$1.05M 0.07%
6,099
-4,308
-41% -$690K
FRPT icon
142
Freshpet
FRPT
$3.22B
$1.01M 0.06%
+6,174
New +$1.05M
RL icon
143
Ralph Lauren
RL
$23.6B
$1M 0.06%
+8,521
New +$1.07M
DOCU
144
DocuSign
DOCU
$11.5B
$974K 0.06%
3,484
+483
+16% +$108K
OTLY
145
Oatly Group
OTLY
$438M
$938K 0.06%
+1,918
New +$953K
EPAM icon
146
EPAM Systems
EPAM
$5.03B
$838K 0.05%
1,641
-66
-4% -$30.9K
INTU icon
147
Intuit
INTU
$89B
$832K 0.05%
1,698
-810
-32% -$351K
ZM icon
148
Zoom
ZM
$30.6B
$789K 0.05%
2,038
-975
-32% -$325K
TER icon
149
Teradyne
TER
$59.3B
$778K 0.05%
5,811
– –
TPR icon
150
Tapestry
TPR
$32.8B
$764K 0.05%
17,565
-2,637
-13% -$118K
4 5
6
7 8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Nicholas Investment Partners held 226 positions worth $1.59B, up 11% from $1.43B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Nicholas Investment Partners withdrew a net $54.6M in Q2 2021, closing 27 positions and reducing 63 holdings. Its most notable exit was Deciphera Pharmaceuticals, Inc. Common Stock, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 48% a quarter earlier, followed by Technology and Financials.

Against the trend, Nicholas Investment Partners opened a new position in Mirati Therapeutics, Inc. Common Stock worth $19.2M.

  • Nicholas Investment Partners's largest Q2 2021 buy was Mirati Therapeutics, Inc. Common Stock: 118,591 shares worth $19.2M.
  • Nicholas Investment Partners added most to Amyris Inc. in Q2 2021, an estimated $14.3M increase.
  • Nicholas Investment Partners's biggest Q2 2021 reduction was NovoCure, cutting an estimated $14.8M.
  • Nicholas Investment Partners fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2021, selling an estimated $20M.
  • Nicholas Investment Partners's ten largest holdings make up 17% of its $1.59B portfolio in Q2 2021.
  • Nicholas Investment Partners opened 31 new positions and closed 27 in Q2 2021.
  • Nicholas Investment Partners's portfolio value rose 11% quarter-over-quarter to $1.59B.

Based on Nicholas Investment Partners's 13F filing for Q2 2021, filed 10 Aug 2021.